N-(Carboxymethyl)lysine induces γ-glutamylcysteine synthetase in RAW264.7 cells
- 1 August 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 296 (1) , 32-40
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Educación, Cultura y Deporte
This publication has 43 references indexed in Scilit:
- Receptor for Advanced Glycation End Products Mediates Inflammation and Enhanced Expression of Tissue Factor in Vasculature of Diabetic Apolipoprotein E–Null MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Inhibition of ERK and p38 MAP Kinases Inhibits Binding of Nrf2 and Induction of GCS GenesBiochemical and Biophysical Research Communications, 2000
- Overexpression of γ-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1Oncogene, 1999
- Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling PathwaysJournal of Biological Chemistry, 1999
- Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.Journal of Clinical Investigation, 1997
- Long Exposure to High Glucose Concentration Impairs the Responsive Expression of γ-Glutamylcysteine Synthetase by Interleukin-1β and Tumor Necrosis Factor-α in Mouse Endothelial CellsJournal of Biological Chemistry, 1996
- Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.Journal of Clinical Investigation, 1995
- Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.Journal of Clinical Investigation, 1992
- Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue RemodelingScience, 1988
- Multiple nuclear factors interact with the immunoglobulin enhancer sequencesCell, 1986